<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/01E53956-BF13-4C46-88E2-94DD05716E14"><gtr:id>01E53956-BF13-4C46-88E2-94DD05716E14</gtr:id><gtr:name>Centre for Cooperative Research in Biomaterials (CIC BiomaGUNE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C93E7E42-62D5-4BB9-BD66-35A8408B9607"><gtr:id>C93E7E42-62D5-4BB9-BD66-35A8408B9607</gtr:id><gtr:name>University Hospitals of Geneva</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/202BB192-329D-4641-9824-6A51C1BDFF8F"><gtr:id>202BB192-329D-4641-9824-6A51C1BDFF8F</gtr:id><gtr:name>Istituto Clinico Humanitas</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A8C54FF8-0CA0-45DE-84DC-6830C296B128"><gtr:id>A8C54FF8-0CA0-45DE-84DC-6830C296B128</gtr:id><gtr:name>Sigma-Tau Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4C02B63A-6450-44EE-B38C-5D2C0C38D1E8"><gtr:id>4C02B63A-6450-44EE-B38C-5D2C0C38D1E8</gtr:id><gtr:name>University of Rome II (Tor Vergata)</gtr:name><gtr:address><gtr:line1>via Columbia, 2</gtr:line1><gtr:line4>Roma</gtr:line4><gtr:line5>I-00133</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/01E53956-BF13-4C46-88E2-94DD05716E14"><gtr:id>01E53956-BF13-4C46-88E2-94DD05716E14</gtr:id><gtr:name>Centre for Cooperative Research in Biomaterials (CIC BiomaGUNE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C93E7E42-62D5-4BB9-BD66-35A8408B9607"><gtr:id>C93E7E42-62D5-4BB9-BD66-35A8408B9607</gtr:id><gtr:name>University Hospitals of Geneva</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/202BB192-329D-4641-9824-6A51C1BDFF8F"><gtr:id>202BB192-329D-4641-9824-6A51C1BDFF8F</gtr:id><gtr:name>Istituto Clinico Humanitas</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8C54FF8-0CA0-45DE-84DC-6830C296B128"><gtr:id>A8C54FF8-0CA0-45DE-84DC-6830C296B128</gtr:id><gtr:name>Sigma-Tau Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4C02B63A-6450-44EE-B38C-5D2C0C38D1E8"><gtr:id>4C02B63A-6450-44EE-B38C-5D2C0C38D1E8</gtr:id><gtr:name>University of Rome II (Tor Vergata)</gtr:name><gtr:address><gtr:line1>via Columbia, 2</gtr:line1><gtr:line4>Roma</gtr:line4><gtr:line5>I-00133</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C5769926-CC08-4385-B7EA-8973E2C334F6"><gtr:id>C5769926-CC08-4385-B7EA-8973E2C334F6</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Child</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2C32BD53-810D-456C-8D78-33AF23232E95"><gtr:id>2C32BD53-810D-456C-8D78-33AF23232E95</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Kennedy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/48CF73D6-9C4B-4384-8DAE-76617F8FA3AF"><gtr:id>48CF73D6-9C4B-4384-8DAE-76617F8FA3AF</gtr:id><gtr:firstName>Caroline</gtr:firstName><gtr:surname>Milner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3E049216-D7C5-40EE-929B-4B642DABE478"><gtr:id>3E049216-D7C5-40EE-929B-4B642DABE478</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Day</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701180"><gtr:id>FC8B24A7-CC0A-4D73-B274-C009A807FE06</gtr:id><gtr:title>Investigation of the roles of TSG-6 and inter-alpha-inhibitor in female fertility</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701180</gtr:grantReference><gtr:abstractText>Infertility is an issue that affects many families in the UK, with around one in six couples attending fertility clinics. However, for many patients the cause of infertility is unclear. By improving our basic understanding of the molecular processes that occur during ovulation (i.e. the release of an oocyte (or egg) from the ovary) we hope to aid the development of more effective treatments for infertile women. Our research will focus on two proteins called TSG-6 and I-alpha-I. We already know that mice that do not synthesise either one of these proteins cannot produce oocytes that are fertilisable. In a mammalian ovary, each oocyte is contained in a separate follicle and before ovulation the oocyte becomes surrounded by a jelly-like substance. This jelly protects the oocyte during release from the ovary and provides a large surface area that aids sperm binding, which is essential for fertilisation. We have shown that both TSG-6 and I-alpha-I have critical roles in forming the jelly and now have new evidence suggesting that these proteins might also be involved in controlling the breakdown of the ovarian follicle wall to allow oocyte release. We will use various methods to further investigate TSG-6 and I-alpha-I in ovulation. For example, we have developed molecular tools that will allow us to look (e.g. using microscopy) at exactly when and where these proteins are present in mouse ovaries and how they might work together in association with other moelcules. Although studies on the mouse can tell us much about ovulation in general, if our results are to be relevant to the development of treatments for infertility, we must be certain that any processes we identify as being important in mice also occur in humans. A new method called ?in vitro maturation of oocytes?, or IVM, which is just beginning to be used to treat infertile women in the UK will allow us to test this, using material left over from treatments. This is a joint project between researchers at the University of Manchester, who have many years of experience in studying TSG-6 and I-alpha-I and are world-leaders in this field, and clinicians at the Oxford Fertility Unit ? the first centre in the UK to achieve pregnancies using the IVM procedure. The combination of expertise from these two groups represents a unique opportunity to carry out this important study.</gtr:abstractText><gtr:technicalSummary>The aim of this work is to investigate fundamental mechanisms that are necessary for female fertility and determine whether processes characterised in the mouse also occur in humans. The proposal focuses on TSG-6 and inter-alpha-inhibitor (IalphaI), proteins that have been shown in mice to be essential for the stabilisation of a nascent matrix that forms around the oocyte (termed cumulus-oocyte complex (COC) expansion) and is necessary for successful ovulation and fertilisation in vivo. The major component of this matrix is the polysaccharide hyaluronan (HA), which is believed to become cross-linked, although, at present this is poorly understood. 
 We have shown that TSG-6 catalyses the transfer of heavy chains (HC) from IalphaI onto HA to form covalent HC-HA complexes, where interactions between HC have been implicated in matrix cross-linking. To more fully understand COC expansion we will use specific antibodies to determine the spatial/temporal distributions of TSG-6, HA and HCs in mouse ovaries. We will also test whether mutants of recombinant human TSG-6 (defective, e.g. in HA binding and/or HC-HA formation) can rescue the ex vivo expansion of tsg-6-null COCs (as already shown for the WT human protein). Access to in vitro matured (IVM) COCs, from women undergoing treatment for infertility, will provide a unique opportunity to investigate whether mouse and human ovulation involve similar mechanisms. For example, we will measure the release of TSG-6 into the IVM culture medium (by ELISA) and the localisation of TSG-6 and its ligands within the human cumulus matrix by immunofluorescence.
 In addition to COC expansion, successful ovulation requires follicle rupture involving proteolytic enzymes, e.g. plasmin. Co-association of TSG-6 with the bikunin chain of IalphaI and certain sulphated glycosaminoglycans substantially enhances the anti-plasmin activity of IalphaI. Our preliminary data indicate that TSG-6 co-localises with anticoagulant heparan sulphate (aHS) in murine ovulating follicles. Reduced TSG-6 immunostaining in Hs3st1-null mouse follicles (which cannot synthesise aHS) suggests that aHS-proteoglycans might sequester TSG-6 or TSG-6/IalphaI complexes and thereby regulate proteolysis during ovualtion. We will investigate whether aHS (from follicular fluids) modulates the anti-plasmin activity of TSG-6/IalphaI and extend our studies on Hs3st1-null follicles to determine the effect of TSG-6 on proteolysis in ovulation.
 This study will provide important insights into molecular mechanisms involved in ovulation, while the analysis of patient samples will indicate whether defects in these processes might account for some cases of infertility and potentially lead to improved fertility treatments.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>565717</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sigma-Tau Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Structural and functional studies on PTX3 - a key component of cumulus matrix.</gtr:description><gtr:id>8ACC6CB0-8431-433A-9ED1-B57BBCE6D63B</gtr:id><gtr:impact>1 primary paper in J. Biol. Chem. (2010)
1 primary paper in Matrix Biol.
1 primary paper in Arterioscl. Throm. Vas. (2012)
Abstract at 36th FEBS Congress, Torino, Italy (2011).</gtr:impact><gtr:partnerContribution>Provision of research reagents.</gtr:partnerContribution><gtr:piContribution>Used reagents provided in our research.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rome Tor Vergata</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Public Health and Cell Biology</gtr:department><gtr:description>The role of TSG-6 in cumulus expansion.</gtr:description><gtr:id>95001CAF-A9E5-4262-B1A6-A7C9408D39EC</gtr:id><gtr:impact>1 Primary paper in Matrix Biology (2011).
Abstract at 6th International Conference on Proteoglycans (2009).
Abstract at BSMB Spring Meeting (2010). 
Abstract at Gordon Research Conference on Proteoglycans (2010).
Abstract at BSMB Autumn Meeting (2010).
Abstract at Fertility 2011.</gtr:impact><gtr:partnerContribution>Conducting experiments using reagents we provided.</gtr:partnerContribution><gtr:piContribution>Provision of research reagents.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Istituto Clinico Humanitas</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Structural and functional studies on PTX3 - a key component of cumulus matrix.</gtr:description><gtr:id>91EF5CA1-3442-411B-8FC1-09A9807EC392</gtr:id><gtr:impact>1 primary paper in J. Biol. Chem. (2010)
1 primary paper in Matrix Biol.
1 primary paper in Arterioscl. Throm. Vas. (2012)
Abstract at 36th FEBS Congress, Torino, Italy (2011).</gtr:impact><gtr:partnerContribution>Provision of research reagents.</gtr:partnerContribution><gtr:piContribution>Used reagents provided in our research.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals of Geneva</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Department of Gynaecology and Obstetrics</gtr:department><gtr:description>The role of TSG-6 and inter-alpha-inhibitor in female fertility.</gtr:description><gtr:id>5CBEC658-E8D7-4146-BA8E-C743A9AD7CDA</gtr:id><gtr:impact>Abstract at BSMB Autumn meeting (2010).
Abstract at Fertility 2011, Dublin, Ireland.
Abstract at 2nd Biomedical Imaging Institute Imaging Methods Showcase, Manchester, UK (2011).
Abstract at 7th International Conference on Proteoglycans, Sydney, Australia (2011).</gtr:impact><gtr:partnerContribution>Provision of clinical samples to enable our research.Provision of mouse tissues and research reagents to support our research.</gtr:partnerContribution><gtr:piContribution>Use of reagents, mouse/human tissues and clinical samples in our research.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centre for Cooperative Research in Biomaterials (CIC BiomaGUNE)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Biosurfaces Research Unit</gtr:department><gtr:description>Use of surface-sensitive techniques to investigate the molecular basis of matrix remodelling.</gtr:description><gtr:id>FB83D849-B9B0-45B7-822A-5F975AC8D19A</gtr:id><gtr:impact>4 primary papers in J. Biol. Chem. (2011, 2013, 2014, 2015).
Abstract at Biological Surfaces and Interfaces, Sant Feliu de Guixols, Spain (2009).
Abstract at 6th International Conference on Proteoglycans, Aix les Bains, France (2009).
2 abstracts at 8th International Conference on Hyaluronan, Kyoto, Japan (2010).
2 abstract at ESF-EMBO Symposium on Biosurfaces and Interfaces, Sant Feliu de Guixols, Spain (2011).
Abstract at Biophysical Society 58th Annual Meeting, San Francisco, USA (2014).
Talk at Gordon Research Conference on Proteoglycans, Andover, USA (2012).
Talk at International Society of Hyaluronan Sciences, Oklahoma City, USA (2013).
3 abstracts at International Society for Hyaluronan Sciences HA2013, Oklahoma City, USA (2013)
Talk at ESF-EMBO Symposium on Biosurfaces and Interfaces, Sant Feliu de Guixols, Spain (2013).
Abstract at Biophysical Society 58th Annual Meeting, San Francisco, USA (2014). 
Talk at 10th International Meeting on Hyaluronan, Florence, Italy (2015).</gtr:impact><gtr:partnerContribution>Experiments performed by these collaborators (using reagents we have supplied), and work done in our lab using reagents supplied by this collaborator, have provided novel insights into the molecular interactions that contribute to inflammatory processes and ovulation.</gtr:partnerContribution><gtr:piContribution>We have provided reagents and input to the design of experiments and interpretation of results; and used reagents from this collaborator in our own research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Obstetrics &amp; Gynaecology</gtr:department><gtr:description>Understanding the mechanism of cumulus expansion</gtr:description><gtr:id>BB5E4A99-4E1D-45D0-BBC2-51A465EE06AD</gtr:id><gtr:impact>1 paper in Reproduction (2015); 1 paper in preparation.</gtr:impact><gtr:partnerContribution>The partners used reagents that we provided in their research, which has provided novel insights into the mechanism of ovulation.</gtr:partnerContribution><gtr:piContribution>We supplied reagents that were used in this collaboration and helped interpret the results obtained.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Obstetrics &amp; Gynaecology</gtr:department><gtr:description>The role of TSG-6 and inter-alpha-inhibitor in female fertility.</gtr:description><gtr:id>548CFB87-10E1-4488-A02F-4206FA0205EE</gtr:id><gtr:impact>Abstract at BSMB Autumn meeting (2010).
Abstract at Fertility 2011, Dublin, Ireland.
Abstract at 2nd Biomedical Imaging Institute Imaging Methods Showcase, Manchester, UK (2011).
Abstract at 7th International Conference on Proteoglycans, Sydney, Australia (2011).</gtr:impact><gtr:partnerContribution>Provision of clinical samples to enable our research.Provision of mouse tissues and research reagents to support our research.</gtr:partnerContribution><gtr:piContribution>Use of reagents, mouse/human tissues and clinical samples in our research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits. Manchester.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A50B1ED7-428B-48C3-A3BB-AE235B9795D9</gtr:id><gtr:impact>Final year undergraduate students (as a part of education projects in the PI and co-I's lab) trialed teaching resources for Key Stage 4 students (14-16 year old) and A level students focused on ovulation and fertilisation at three different Manchester schools and at a museum workshop (~100 pupils in total).

Two of the schools and museum indicated that they will use the resources in future years for their teaching on reproductive biology.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The official opening of the new Oxford Fertility Unit.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5D2B2B7D-CA68-463B-B05C-7189D1FEB660</gtr:id><gtr:impact>One of the co-applicants on this grant presented an overview of research (including our project) as part of the official opening of the Oxford Fertility Unit, following its move to new premises.

It raised awareness of the importance of basic research being done in parallel with the clinical activities of the Fertility Unit.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshops for Manchester schools on inflammation.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CE160351-904F-4929-9C3B-3F58D9492133</gtr:id><gtr:impact>Final year undergraduate 'Education' project aimed at GCSE and A level students; workshops on inflammation and inflammatory disease were delivered as part of a Manchester Museum Activity Day for Schools and revision activities on these topics were delivered to GCSE students at a Manchester school. Positive feedback from students and their teachers and interest was stimulated in studying science degrees at university.

Positive feedback to project supervisor on the value of the school visit and the quality/impact of the content delivered.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75281</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CASE Studentship with Farfield Group Ltd</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>8F314668-5A14-4B0B-A70F-545404675BD2</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Doctoral Training Award</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D41E9867-288F-4D9E-A4E4-48D462F2766B</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>531022</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARUK Programme Grant</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>9C19C062-C2E7-4BF8-B762-1E0F903D7492</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>185377</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARUK Project Grant (The role of inter-alpha-inhibitor in arthritis: friend or foe?)</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>AAF48F87-AC0D-4521-96DD-9815C9A3B07D</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99832</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Non-clinical PhD Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/10/52/28678</gtr:fundingRef><gtr:id>9D06B76C-2C96-4AA9-9540-FFDA40870D64</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>127983</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Univerity of Manchester and A*STAR PhD Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>University of Manchester</gtr:fundingOrg><gtr:id>EC56E701-F85B-4B01-85CA-7CE036BCFD90</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Antisera raised in rabbits against murine HC1, HC2, HC3 and bikunin (i.e. the protein chains of inter-alpha-inhibitor).</gtr:description><gtr:id>8B35AB46-4A6B-43E5-9125-958CFB5BBF66</gtr:id><gtr:impact>Localization of these proteins within the mouse ovary prior to ovulation.
Paper in preparation.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Chain specific antibodies for mouse inter-alpha-inhibitor</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Immature COCs recovered from patients undergoing surgery are now available (under ethics). These can be matured in vitro and are allowing us to perform fluorescent microscopy to determine the spatial/temporal distribution of TSG-6, hyaluronan and inter-alpha-inhibitor within the human cumulus matrix.</gtr:description><gtr:id>E0E76C63-6F0F-42B3-9E0E-1B252F12EB6D</gtr:id><gtr:impact>This work is allowing us to determine whether the same molecular processes occur in the human and mouse, where the results are likely to aid improvements in IVM.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human COCs from patients undergoing surgery</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have detected TSG-6 (a protein already established as having a key role in mouse ovulation) within the cumulus matrix surrounding oocytes collected for IVF or cultured in vitro for IVM. This provides novel insights into the mechanism of human ovulation.</gtr:description><gtr:id>44B6AEC9-3DB0-49AD-BAA0-49ACDEFCFF30</gtr:id><gtr:impact>Work is in progress to determine whether TSG-6 could be used as a biomarker to aid with IVF/IVM procedures.
Paper in preparation.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Detection of TSG-6 protein associated with human IVF and IVM oocytes</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Recombinant heavy chains from human inter-alpha-inhibitor and pre-alpha-inhibitor (wild and mutant proteins).</gtr:description><gtr:id>0DAB1D59-0062-40F6-A933-676AF616FCEC</gtr:id><gtr:impact>1 paper published (Baranova et al., 2013 J. Biol. Chem.) and other papers are in preparation.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Recombinant heavy chains from human inter-alpha-inhibitor.</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F05E1E8-CA57-4E87-A519-726B5609CE85"><gtr:id>5F05E1E8-CA57-4E87-A519-726B5609CE85</gtr:id><gtr:title>Sulfation of the bikunin chondroitin sulfate chain determines heavy chain&amp;middot;hyaluronan complex formation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/18e48ceaf11d2b1819fd02bc2b9d6c4e"><gtr:id>18e48ceaf11d2b1819fd02bc2b9d6c4e</gtr:id><gtr:otherNames>Lord MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B76FF67E-4171-425C-89F0-E9F5F33E4D12"><gtr:id>B76FF67E-4171-425C-89F0-E9F5F33E4D12</gtr:id><gtr:title>Inter-a-inhibitor impairs TSG-6-induced hyaluronan cross-linking.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8e45bf2afae18912ae6ded3cbc1497f"><gtr:id>f8e45bf2afae18912ae6ded3cbc1497f</gtr:id><gtr:otherNames>Baranova NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C530B5B-7CE6-4B1C-9213-AD6EB5CA79B6"><gtr:id>3C530B5B-7CE6-4B1C-9213-AD6EB5CA79B6</gtr:id><gtr:title>A refined model for the TSG-6 link module in complex with hyaluronan: use of defined oligosaccharides to probe structure and function.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a40cd198eab6deb0c45bf2a2a4c8e952"><gtr:id>a40cd198eab6deb0c45bf2a2a4c8e952</gtr:id><gtr:otherNames>Higman VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/64611029-D7E5-4945-8C8E-74E71E5C404E"><gtr:id>64611029-D7E5-4945-8C8E-74E71E5C404E</gtr:id><gtr:title>Molecular analysis of the cumulus matrix: insights from mice with O-glycan-deficient oocytes.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93dcd7a1c8b3b596385574d7740791e8"><gtr:id>93dcd7a1c8b3b596385574d7740791e8</gtr:id><gtr:otherNames>Ploutarchou P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BA5E4E3-F1E4-4EA2-AA11-078C467187D8"><gtr:id>3BA5E4E3-F1E4-4EA2-AA11-078C467187D8</gtr:id><gtr:title>Incorporation of pentraxin 3 into hyaluronan matrices is tightly regulated and promotes matrix cross-linking.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8e45bf2afae18912ae6ded3cbc1497f"><gtr:id>f8e45bf2afae18912ae6ded3cbc1497f</gtr:id><gtr:otherNames>Baranova NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F463519-88C4-42DA-879A-1A5B24210931"><gtr:id>3F463519-88C4-42DA-879A-1A5B24210931</gtr:id><gtr:title>Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/94faf8be0a744b355d72a2bc1348de38"><gtr:id>94faf8be0a744b355d72a2bc1348de38</gtr:id><gtr:otherNames>Leali D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F289EE7-1F33-4150-BB69-F1CB79DEB36D"><gtr:id>7F289EE7-1F33-4150-BB69-F1CB79DEB36D</gtr:id><gtr:title>Hyaluronan, TSG-6, and inter-a-inhibitor in periprosthetic breast capsules: reduced levels of free hyaluronan and TSG-6 expression in contracted capsules.</gtr:title><gtr:parentPublicationTitle>Aesthetic surgery journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/73c92f074e1d15e99d93957587f74b1f"><gtr:id>73c92f074e1d15e99d93957587f74b1f</gtr:id><gtr:otherNames>Tan KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-820X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/17AAC2BB-89FA-4355-B23B-AE0AF335EA24"><gtr:id>17AAC2BB-89FA-4355-B23B-AE0AF335EA24</gtr:id><gtr:title>The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52730ee8045556680a1015c928eb1ea0"><gtr:id>52730ee8045556680a1015c928eb1ea0</gtr:id><gtr:otherNames>Inforzato A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/430549AB-9575-4C49-B69D-956F8E11F728"><gtr:id>430549AB-9575-4C49-B69D-956F8E11F728</gtr:id><gtr:title>Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly.</gtr:title><gtr:parentPublicationTitle>Matrix biology : journal of the International Society for Matrix Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0b070011a1e22b530a5aaeef5d3788a"><gtr:id>e0b070011a1e22b530a5aaeef5d3788a</gtr:id><gtr:otherNames>Ievoli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0945-053X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E63D8C71-51C0-4597-9C29-16618211EF2B"><gtr:id>E63D8C71-51C0-4597-9C29-16618211EF2B</gtr:id><gtr:title>The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8e45bf2afae18912ae6ded3cbc1497f"><gtr:id>f8e45bf2afae18912ae6ded3cbc1497f</gtr:id><gtr:otherNames>Baranova NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5434CF96-1A69-47A7-AB8C-1EC935B6AF45"><gtr:id>5434CF96-1A69-47A7-AB8C-1EC935B6AF45</gtr:id><gtr:title>Modulation of tumor necrosis factor-stimulated gene-6 (TSG-6) expression in human endometrium.</gtr:title><gtr:parentPublicationTitle>Archives of gynecology and obstetrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5248345d1cadcebbc4bc787c0244910"><gtr:id>e5248345d1cadcebbc4bc787c0244910</gtr:id><gtr:otherNames>Capp E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0932-0067</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F094084C-6EB9-4751-824D-E69DE04C5C11"><gtr:id>F094084C-6EB9-4751-824D-E69DE04C5C11</gtr:id><gtr:title>Metal Ion-dependent Heavy Chain Transfer Activity of TSG-6 Mediates Assembly of the Cumulus-Oocyte Matrix.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1f38c64969cbbeb61c0b598d79fc8c33"><gtr:id>1f38c64969cbbeb61c0b598d79fc8c33</gtr:id><gtr:otherNames>Briggs DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701180</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>